Anthem joins CivicaRx’s division to bring lower-cost generic drugs to pharmacies. The first patient receives the controversial newly approved Alzheimer's medicine. And some research finds vaccine mixing holds promise.
Hosted on Acast. See acast.com/privacy for more information.
